22 days ago
Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice
What's happening
SignalsMonitor is following this as a technology story. Phys.org Breaking News is the outlet attached so far. The first report grouped here was at 25 Sept 2026, 16:00 UTC. The headline in use is “Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, so by the time a tumor takes hold, it's often already shielded from the immune system and…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Phys.org Breaking News
Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice
Reported by 1 outlet
- Phys.org Breaking News
- Phys.org Breaking NewsTargeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice